Schroder UK Public Private Trust plc announced the appointment of Tim Edwards as an independent non-executive director of the Company, effective 26 February 2021. Mr Edwards will stand for election at the Company's next Annual General Meeting ("AGM") and if elected, will succeed Susan Searle as Chairman of the Company following her retirement once the AGM has concluded. Mr. Edwards has also been appointed a member of the Audit, Risk and Valuation, Management Engagement and Nomination Committees. Tim is a qualified chartered accountant with a widespread background in corporate finance and investment. He is currently the chairman of Storm Therapeutics Ltd, Karus Therapeutics Ltd. and Modulus Oncology Ltd, a director of AstronauTx Ltd. and an independent non-executive director of Record plc. Previously, Tim was a member of the governing board of InnovateUK, the UK's innovation agency, a director of the UK Cell and Gene Therapy Catapult and chairman of the UK BioIndustry Association.